NCT05252442View on ClinicalTrials.gov

Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 Vaccines

CompletedOBSERVATIONAL
Enrollment

7,641,136

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

July 11, 2023

Study Completion Date

July 11, 2023

Conditions
Covid-19
Interventions
OTHER

Pre-COVID-19

Pre-COVID-19 period

OTHER

COVID-19

COVID-19 period

OTHER

COVID-19 vaccination roll-out

COVID-19 vaccination roll-out period

Trial Locations (1)

OX12JD

Research site, Oxford

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY